Xiangao Jiang Selected Research

COVID-19

11/2023	Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study.
1/2023	Efficacy and safety of Nirmatrelvir/Ritonavir for treating the Omicron variant of COVID-19.
10/2020	A Deep Learning System to Screen Novel Coronavirus Disease 2019 Pneumonia.
9/2020	Differential diagnosis for suspected cases of coronavirus disease 2019: a retrospective study.
1/2020	Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiangao Jiang Research Topics

Disease

5	COVID-19 11/2023 - 01/2020
3	Drug-Related Side Effects and Adverse Reactions 01/2024 - 01/2023
3	Pulmonary Tuberculosis 01/2023 - 01/2022
2	Human Influenza (Influenza) 01/2024 - 09/2020
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022 - 01/2019
2	Infections 01/2022 - 09/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	Lung Diseases (Lung Disease) 01/2023
1	Hepatitis 01/2023
1	Tuberculous Peritonitis 01/2022
1	Abscess 01/2022
1	Inflammation (Inflammations) 01/2022
1	Leptospirosis 01/2022
1	Tuberculosis (Tuberculoses) 01/2022
1	Hepatic Tuberculosis 01/2022
1	Disease Progression 01/2022
1	Hypoalbuminemia 01/2022
1	Extensively Drug-Resistant Tuberculosis 01/2022
1	Dysbiosis 01/2022
1	Fever (Fevers) 01/2021
1	Pneumonia (Pneumonitis) 09/2020
1	Dyspnea (Shortness of Breath) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Lung Neoplasms (Lung Cancer) 03/2016
1	Carcinoma (Carcinomatosis) 03/2016
1	Hepatitis B 09/2015

Drug/Important Bio-Agent (IBA)

2	Antiviral Agents (Antivirals)IBA 11/2023 - 09/2015
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2022
2	Nucleic AcidsIBA 01/2023 - 09/2020
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2022 - 01/2022
2	C-Reactive ProteinIBA 01/2022 - 01/2020
1	baloxavirIBA 01/2024
1	Therapeutic UsesIBA 01/2024
1	TabletsIBA 01/2024
1	Oseltamivir (Tamiflu)FDA Link 01/2024
1	GS-621763IBA 11/2023
1	nirmatrelvir and ritonavir drug combinationIBA 01/2023
1	4-trifluoromethylsalicylic acid (HTB)IBA 01/2022
1	Moxifloxacin (Avelox)FDA Link 01/2022
1	Acetyl-CoA CarboxylaseIBA 01/2022
1	AcidsIBA 01/2022
1	Amikacin (A.M.K)FDA LinkGeneric 01/2022
1	Capreomycin (Capastat)FDA Link 01/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2022
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2022
1	Kanamycin FDA Link 01/2022
1	Streptomycin (Streptomycin Sulfate)FDA Link 01/2022
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 01/2022
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2022
1	Transaminases (Aminotransferases)IBA 01/2021
1	Viral RNAIBA 10/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2020
1	2,5-dichloro-4-bromophenol (B 2)IBA 09/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	LactaseIBA 01/2020
1	Pyrazinamide FDA LinkGeneric 01/2019
1	rottlerinIBA 01/2018
1	CateninsIBA 03/2016
1	MicroRNAs (MicroRNA)IBA 03/2016
1	DNA (Deoxyribonucleic Acid)IBA 09/2015

Therapy/Procedure

2	Therapeutics 03/2016 - 09/2015
1	Lasers (Laser) 01/2023
1	Patient Readmission 01/2023
1	Renal Dialysis (Hemodialysis) 01/2022
1	Retreatment 01/2022